CERo Therapeutics Holdings, Inc.
CERO · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $6,438 | $4,700 | $2,502 | $14,495 |
| - Cash | $2,022 | $3,303 | $5,204 | $3,327 |
| + Debt | $931 | $1,153 | $1,367 | $1,575 |
| Enterprise Value | $5,347 | $2,550 | -$1,335 | $12,744 |
| Revenue | $0 | $0 | $0 | $1,163 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | -$268 | -$269 | $581 |
| % Margin | – | – | – | 50% |
| EBITDA | -$4,363 | -$5,163 | -$4,837 | $1,546 |
| % Margin | – | – | – | 132.9% |
| Net Income | -$11,506 | -$5,417 | -$5,106 | $1,244 |
| % Margin | – | – | – | 107% |
| EPS Diluted | -9.1 | -61.71 | -3.18 | 0.56 |
| % Growth | 85.3% | -1,840.6% | -667.9% | – |
| Operating Cash Flow | -$3,205 | -$4,623 | -$4,446 | $4,146 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$3,205 | -$4,623 | -$4,446 | $4,146 |